Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Medigene AG (XETRA: MDG1)

 
MDG1 Technical Analysis
5
As on 23rd Dec 2024 MDG1 STOCK Price closed @ 1.03 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.63 & Strong Sell for SHORT-TERM with Stoploss of 1.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MDG1STOCK Price

Open 1.02 Change Price %
High 1.05 1 Day 0.00 0.00
Low 1.00 1 Week -0.06 -5.50
Close 1.03 1 Month -0.48 -31.79
Volume 30280 1 Year -0.86 -45.50
52 Week High 2.72 | 52 Week Low 1.01
 
XETRA Germany Most Active Stocks
LHAR 2.05 -20.23%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BVBA 0.02 -60.00%
SNH 0.16 6.67%
SNH 0.16 6.67%
SNH 0.16 6.67%
PHIA 31.36 1.92%
PHIA 31.36 1.92%
 
XETRA Germany Top Gainers Stocks
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
VROS 0.04 100.00%
VROS 0.04 100.00%
VROS 0.04 100.00%
PAG 0.02 100.00%
 
XETRA Germany Top Losers Stocks
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
IQL 0.02 -66.67%
IQL 0.02 -66.67%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
LEO 0.04 -63.64%
 
 
MDG1
Daily Charts		 MDG1
Intraday Charts		 Whats New @
Bazaartrend		 MDG1
Free Analysis
 
MDG1 Important Levels Intraday
RESISTANCE1.13
RESISTANCE1.10
RESISTANCE1.08
RESISTANCE1.06
SUPPORT1.00
SUPPORT0.98
SUPPORT0.96
SUPPORT0.93
 
MDG1 Forecast December 2024
Share
4th UP Forecast1.42
3rd UP Forecast1.29
2nd UP Forecast1.22
1st UP Forecast1.14
1st DOWN Forecast0.92
2nd DOWN Forecast0.84
3rd DOWN Forecast0.77
4th DOWN Forecast0.64
 
MDG1 Weekly Forecast
4th UP Forecast1.42
3rd UP Forecast1.29
2nd UP Forecast1.22
1st UP Forecast1.14
1st DOWN Forecast0.92
2nd DOWN Forecast0.84
3rd DOWN Forecast0.77
4th DOWN Forecast0.64
 
MDG1 Forecast2024
4th UP Forecast4.73
3rd UP Forecast3.54
2nd UP Forecast2.81
1st UP Forecast2.08
1st DOWN Forecast-0.02
2nd DOWN Forecast-0.75
3rd DOWN Forecast-1.48
4th DOWN Forecast-2.67
 
 
MDG1 Other Details
Segment EQ
Market Capital 87688840.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
MDG1 Address
MDG1
 
MDG1 Latest News
 
Your Comments and Response on Medigene AG
 
MDG1 Business Profile
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies, with a focus on T cell receptor-modified T cells in areas of unmet medical needs, which are in clinical development. It also focuses on dendritic cell vaccines and T cell-specific monoclonal antibodies. In addition, the company focuses on developing and marketing RhuDex for hepatology and gastroenterology indications. Medigene AG has a strategic partnership with bluebird bio, Inc. for the development of T cell receptors. The company also has research collaboration agreements on novel cancer antigens for immunotherapies with the Université de Montréal; and with Cytovant Sciences Co. Ltd. It has operations in Europe, the United States, Asia, and internationally. The company was founded in 1994 and is headquartered in Munich, Germany. Address: Lochhamer Strasse 11, Munich, Germany, 82152
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service